tiprankstipranks
Advertisement
Advertisement

BMRN Stock Latest News

Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
RatingsJason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
3d ago
BMRN
3 Best Stocks to Buy This Week, According to Analysts – May 25-May 29
PremiumMarket News
3 Best Stocks to Buy This Week, According to Analysts – May 25-May 29
10d ago
BMRN
FUTU
BioMarin price target lowered to $111 from $116 at Canaccord
PremiumThe Fly
BioMarin price target lowered to $111 from $116 at Canaccord
13d ago
BMRN
Buy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
14d ago
BMRN
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
PremiumThe Fly
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
14d ago
BMRN
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe FlyStubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
16d ago
AMT
BAP
BioMarin price target lowered to $80 from $85 at BofA
Premium
The Fly
BioMarin price target lowered to $80 from $85 at BofA
16d ago
BMRN
BioMarin initiated with a Buy at Citi
Premium
The Fly
BioMarin initiated with a Buy at Citi
16d ago
BMRN
BioMarin price target lowered to $62 from $64 at Leerink
PremiumThe Fly
BioMarin price target lowered to $62 from $64 at Leerink
16d ago
BMRN
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
PremiumThe Fly
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
17d ago
BMRN
BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
PremiumThe Fly
BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
17d ago
BMRN
Morgan Stanley Sees the S&P 500 Hitting 8,300 – 2 Stocks It Says Could Surge Alongside It
PremiumMarket News
Morgan Stanley Sees the S&P 500 Hitting 8,300 – 2 Stocks It Says Could Surge Alongside It
20d ago
ARXS
BMRN
BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors
PremiumCompany AnnouncementsBioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors
21d ago
BMRN
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
Premium
The Fly
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
23d ago
CG
FTV
BioMarin reinstated with a Neutral at Goldman Sachs
Premium
The Fly
BioMarin reinstated with a Neutral at Goldman Sachs
24d ago
BMRN
BioMarin price target raised to $116 from $104 at Canaccord
PremiumThe Fly
BioMarin price target raised to $116 from $104 at Canaccord
28d ago
BMRN
BioMarin price target lowered to $119 from $120 at Morgan Stanley
PremiumThe Fly
BioMarin price target lowered to $119 from $120 at Morgan Stanley
30d ago
BMRN
BioMarin price target raised to $120 from $110 at Evercore ISI
PremiumThe Fly
BioMarin price target raised to $120 from $110 at Evercore ISI
30d ago
BMRN
BioMarin price target lowered to $82 from $94 at Bernstein
PremiumThe Fly
BioMarin price target lowered to $82 from $94 at Bernstein
30d ago
BMRN
BioMarin: Buy Rating Reiterated on Amicus Acquisition Upside and Pipeline Catalysts; $85 Price Target Unchanged
PremiumRatingsBioMarin: Buy Rating Reiterated on Amicus Acquisition Upside and Pipeline Catalysts; $85 Price Target Unchanged
30d ago
BMRN
BioMarin Buy Rating Reiterated on Amicus Acquisition Synergies and Long-Term Upside; $120 Price Target Unchanged
Premium
Ratings
BioMarin Buy Rating Reiterated on Amicus Acquisition Synergies and Long-Term Upside; $120 Price Target Unchanged
1M ago
BMRN
BioMarin Boosts 2026 Outlook After Amicus Deal
Premium
Company Announcements
BioMarin Boosts 2026 Outlook After Amicus Deal
1M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >